GM-CSF: A role in immune and inflammatory reactions in the intestine

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 6, 2010, Pages 723-731

  Egea, Laia ^a   Hirata, Yoshihiro ^a   Kagnoff, Martin F ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Citrobacter rodentium; colon cancer; dendritic cells; epithelial cells; gastrointestinal infection; GM CSF; GM CSF receptor; inflammatory bowel disease; intestinal homeostasis

Indexed keywords

CANCER VACCINE; CORTICOSTEROID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CANCER IMMUNOTHERAPY; CITROBACTER RODENTIUM; CLINICAL TRIAL; COLITIS; COLORECTAL CANCER; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DIGESTIVE SYSTEM INFLAMMATION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROBACTERIACEAE; GASTROINTESTINAL INFECTION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MUCOSAL IMMUNITY; NONHUMAN; REMISSION; REVIEW; SALMONELLOSIS; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANIMALS; AUTOIMMUNITY; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICE; MICE, KNOCKOUT;

EID: 78649681788     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.73     Document Type: Review

References (71)

1. Fleetwood AJ, Cook AD, Hamilton JA. Functions of granulocyte-macrophage colony-stimulating factor. Crit. Rev. Immunol. 25(5), 405-428 (2005).
2. Hamilton JA. Colony-stimulating factors in infammation and autoimmunity. Nat. Rev. Immunol. 8(7), 533-544 (2008).
3. Dranoff G, Crawford AD, Sadelain M et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264(5159), 713-716 (1994).
4. Stanley E, Lieschke GJ, Grail D et al. Granulocyte/macrophage colony-stimulating factor-defcient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. USA 91(12), 5592-5596 (1994).
5. Paine R 3rd, Preston AM, Wilcoxen S et al. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 164(5), 2602-2609 (2000).
6. LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA. GM-CSF-defcient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103(4), 563-569 (1999).
7. Panja A, Goldberg S, Eckmann L, Krishen P, Mayer L. The regulation and functional consequence of proinfammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161(7), 3675-3684 (1998).
8. Hirsch T, Eggstein S, Frank S, Farthmann EH, von Specht BU. Expression of GM-CSF and a functional GM-CSF receptor in the human colon carcinoma cell line SW403. Biochem. Biophys. Res. Commun. 217(1), 138-143 (1995).
9. Trutmann M, Terracciano L, Noppen C et al. GM-CSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens. Int. J. Cancer 77(3), 378-385 (1998).
10. Hirata Y, Egea L, Dann SM, Eckmann L, Kagnoff MF. GM-CSF-facilitated dendritic cell recruitment and survival govern the itestinal mucosal response to a mouse enteric bacterial pathogen. Cell. Host Microbe 7(2), 151-163 (2010).
11. Coon C, Beagley KW, Bao S. The role of granulocyte macrophage-colony stimulating factor in gastrointestinal immunity to salmonellosis. Scand. J. Immunol. 70(2), 106-115 (2009).
12. Xu Y, Hunt NH, Bao S. The role of granulocyte macrophage-colony- stimulating factor in acute intestinal infammation. Cell. Res. 18(12), 1220-1229 (2008).
13. Sainathan SK, Hanna EM, Gong Q et al. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Infamm. Bowel Dis. 14(1), 88-99 (2008).
14. Bernasconi E, Favre L, Maillard MH et al. Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote effcient colonic mucosal healing. Infamm. Bowel Dis. 16(3), 428-441 (2010).
15. Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360(9344), 1478-1480 (2002).
16. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N. Engl. J. Med. 352(21), 2193-2201 (2005).
17. Takazoe M, Matsui T, Motoya S, Matsumoto T, Hibi T, Watanabe M. Sargramostim in patients with Crohn's disease: results of a Phase 1-2 study J. Gastroenterol. 44(6), 535-543 (2009).
18. Valentine JF, Fedorak RN, Feagan B et al. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, Phase 2 study. Gut 58(10), 1354-1362 (2009).
19. Magno P, Jimenez CE, Ortiz Z, Torres EA. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fstulizing Crohn's disease. P. R. Health Sci. J. 29(1), 60-65 (2010).
20. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77(6), 1131-1145 (1991).
21. Hamilton JA. GM-CSF in infammation and autoimmunity. Trends Immunol. 23(8), 403-408 (2002).
22. Martinez-Moczygemba M, Huston DP. Biology of common b receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112(4), 653-665 (2003).
23. Hansen G, Hercus TR, McClure BJ et al The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134(3), 496-507 (2008).
24. Hercus TR, Thomas D, Guthridge MA et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 114(7), 1289-1298 (2009).
25. Guthridge MA, Stomski FC, Barry EF et al. Site-specifc serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol. Cell. 6(1), 99-108 (2000).
26. Guthridge MA, Powell JA, Barry EF et al. Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. EMBO J. 25(3), 479-489 (2006).
27. Kimura A, Rieger MA, Simone JM et al. The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis. Blood 114(21), 4721-4728 (2009).
28. Sebastian C, Serra M, Yeramian A, Serrat N, Lloberas J, Celada A. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180(9), 5898-5906 (2008).
29. Al-Shami A, Mahanna W, Naccache PH. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b. J. Biol. Chem. 273(2), 1058-1063 (1998).
30. Guthridge MA, Stomski FC, Thomas D et al. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16(5), 301-313 (1998).
31. de Groot RP, Coffer PJ, Koenderman L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 10(9), 619-628 (1998).
32. Choi JK, Choi BH, Ha Y et al. Signal transduction pathways of GM-CSF in neural cell lines. Neurosci. Lett. 420(3), 217-222 (2007).
33. + cell lines. Exp. Hematol. 35(6), 957-966 (2007).
34. Prevost JM, Pelley JL, Zhu W et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and infammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: evidence for ectodomain shedding of the cell surface GM-CSF receptor a subunit. J. Immunol. 169(10), 5679-5688 (2002).
35. Sayani F, Montero-Julian FA, Ranchin V et al. Identifcation of the soluble granulocyte-macrophage colony stimulating factor receptor protein in vivo. Blood 95(2), 461-469 (2000).
36. Raines MA, Liu L, Quan SG, Joe V, DiPersio JF, Golde DW. Identifcation and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc. Natl Acad. Sci. USA 88(18), 8203-8207 (1991).
37. Brown CB, Beaudry P, Laing TD, Shoemaker S, Kaushansky K. In vitro characterization of the human recombinant soluble granulocyte-macrophage colony-stimulating factor receptor. Blood 85(6), 1488-1495 (1995).
38. Fukuzawa H, Sawada M, Kayahara T et al. Identifcation of GM-CSF in Paneth cells using single-cell RT-PCR. Biochem. Biophys. Res. Commun. 312(4), 897-902 (2003).
39. Holowachuk EW, Ruhoff MS. Restoration of abated T cell stimulation activity of mature dendritic cells. Biochem. Biophys. Res. Commun. 285(3), 594-597 (2001).
40. Sennikov SV, Temchura V V, Trufakin VA, Kozlov VA. Effects of granulocyte-macrophage colony-stimulating factor produced by intestinal epithelial cells on functional activity of hemopoietic stem cells. Bull. Exp. Biol. Med. 134(6), 548-550 (2002).
41. Sennikov SV, Temchura V V, Kozlov VA, Trufakin VA. The infuence of conditioned medium from mouse intestinal epithelial cells on the proliferative activity of crypt cells: role of granulocyte-macrophage colony-stimulating factor. J. Gastroenterol. 37(12), 1048-1051 (2002).
42. Han X, Gilbert S, Groschwitz K et al. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury. Gut 59(8), 1066-1078 (2010).
43. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and infammation in the intestine. Cell 140(6), 859-870 (2010).
44. Varol C, Vallon-Eberhard A, Elinav E et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31(3), 502-512 (2009).
45. Bogunovic M, Ginhoux F, Helft J et al. Origin of the lamina propria dendritic cell network. Immunity 31(3), 513-525 (2009).
46. Yokota A, Takeuchi H, Maeda N et al. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int. Immunol. 21(4), 361-377 (2009).
47. Tezuka H, Ohteki T. Regulation of intestinal homeostasis by dendritic cells. Immunol. Rev. 234(1), 247-258 (2010).
48. + regulatory T cells via a TGF-b and retinoic acid-dependent mechanism. J. Exp. Med. 204(8), 1757-1764 (2007).
49. Elias KM, Laurence A, Davidson TS et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111(3), 1013-1020 (2008).
50. Ramsay RG, Micallef SJ, Williams B et al. Colony-stimulating factor-1 promotes clonogenic growth of normal murine colonic crypt epithelial cells in vitro. J. Interferon Cytokine Res. 24(7), 416-427 (2004).
51. Bouma G, Strober W. The immunological and genetic basis of infammatory bowel disease. Nat. Rev. Immunol. 3(7), 521-533 (2003).
52. Basset C, Holton J. Infammatory bowel disease: is the intestine a Trojan horse? Sci. Prog. 85(Pt 1), 33-56 (2002).
53. Mayer L. Evolving paradigms in the pathogenesis of IBD. J. Gastroenterol. 45(1), 9-16 (2010).
54. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin. Pract. Gastroenterol. Hepatol. 3(7), 390-407 (2006).
55. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodefciency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig. Dis. Sci. 45(6), 1121-1129 (2000).
56. Noguchi M, Hiwatashi N, Liu ZX, Toyota T. Increased secretion of granulocyte-macrophage colony-stimulating factor in mucosal lesions of infammatory bowel disease. Digestion 63(Suppl. 1), 32-36 (2001).
57. Ina K, Kusugami K, Hosokawa T et al. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Infammatory Bowel disease. J. Gastroenterol. Hepatol. 14(1), 46-53 (1999).
58. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodefcient mice. Gastroenterology 107(6), 1643-1652 (1994).
59. Metcalf D, Nicola NA, Mifsud S, di Rago L. Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood 93(5), 1579-1585 (1999).
60. Uchida K, Nakata K, Suzuki T et al. Granulocyte/macrophage-colony- stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113(11), 2547-2556 (2009).
61. Meager A, Wadhwa M, Bird C et al. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology 97(3), 526-532 (1999).
62. Svenson M, Hansen MB, Ross C et al. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood 91(6), 2054-2061 (1998).
63. Meager A, Wadhwa M, Dilger P et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-a, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin. Exp. Immunol. 132(1), 128-136 (2003).
64. Uchida K, Beck DC, Yamamoto T et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N. Engl. J. Med. 356(6), 567-579 (2007).
65. Meager A, Cludts I, Thorpe R, Wadhwa M. Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons? Blood 115(2), 433-434 (2010).
66. Han X, Uchida K, Jurickova I et al. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology 136(4), 1261-1271, E1-E3 (2009).
67. Hamilton JA, Anderson GP. GM-CSF biology. Growth Factors 22(4), 225-231 (2004).
68. Greenhill SR, Kotton DN. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest 136(2), 571-577 (2009).
69. Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit. Rev. Immunol. 22(2), 105-114 (2002).
70. Mantovani A, Gray PA, van Damme J, Sozzani S. Macrophage-derived chemokine (MDC). J Leukoc. Biol. 68(3), 400-404 (2000).
71. Shetye J, Ragnhammar P, Liljefors M et al. Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor. Clin. Cancer Res. 4(8), 1921-1929 (1998).